Jesús María
Prieto Valtueña
Ikertzailea 2014-(e)ra arte
Jesús María Prieto Valtueña-rekin lankidetzan egindako argitalpenak (90)
2017
-
Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells
Translational Research, Vol. 188, pp. 80-91.e2
2016
-
Factors related to increased resting energy expenditure in men with liver cirrhosis
European Journal of Gastroenterology and Hepatology, Vol. 28, Núm. 2, pp. 139-145
-
Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria
Journal of Hepatology, Vol. 65, Núm. 4, pp. 776-783
2015
-
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection
Molecular Therapy - Methods and Clinical Development, Vol. 2, pp. 15006
2014
-
Comparación de las sondas M y XL para estimar la rigidez hepática por medio de elastografía de transición
Gastroenterologia y Hepatologia, Vol. 37, Núm. 4, pp. 233-239
2013
-
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Journal of Hepatology, Vol. 59, Núm. 1, pp. 81-88
-
Cytokines for the treatment of gastrointestinal cancers: Clinical experience and new perspectives
Expert Opinion on Investigational Drugs, Vol. 22, Núm. 7, pp. 827-841
-
Increased liver stiffness values in patients with heart failure
Acta Gastro-Enterologica Belgica, Vol. 76, Núm. 2, pp. 246-250
-
Prognostic factors and prevention of radioembolization-induced liver disease
Hepatology, Vol. 57, Núm. 3, pp. 1078-1087
-
Safety and liver transduction efficacy of raav5-cohpbgd in nonhuman primates: A potential therapy for acute intermittent porphyria
Human Gene Therapy, Vol. 24, Núm. 12, pp. 1007-1017
-
Zolmitriptan: A Novel Portal Hypotensive Agent Which Synergizes with Propranolol in Lowering Portal Pressure
PLoS ONE, Vol. 8, Núm. 1
2012
-
Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis B
Hepatology, Vol. 56, Núm. 2, pp. 474-483
-
Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates.
Journal of translational medicine, Vol. 10, pp. 122
2011
-
A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma
Functional and Integrative Genomics, Vol. 11, Núm. 3, pp. 419-429
-
Adeno-associated virus liver transduction efficiency measured by in vivo [ 18F]FHBG positron emission tomography imaging in rodents and nonhuman primates
Human Gene Therapy, Vol. 22, Núm. 8, pp. 999-1009
-
Characterization of woodchuck apolipoprotein A-I: A new tool for drug delivery and identification of altered isoforms in the woodchuck chronic hepatitis model
Journal of Medical Virology, Vol. 83, Núm. 7, pp. 1221-1229
-
Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection
Journal of Hepatology, Vol. 54, Núm. 3, pp. 422-431
-
Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages
Annals of Surgical Oncology, Vol. 18, Núm. 7, pp. 1964-1971
-
Transarterial therapies for hepatocellular carcinoma
Expert Opinion on Pharmacotherapy, Vol. 12, Núm. 7, pp. 1057-1073
-
Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of Interleukin-12
Journal of Virology